Insider trades
Fred Aslan, CEO of Artiva Biotherapeutics ARTV, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $438K. The latest trade was on 05/19.
Fred Aslan
CEO
- Company
- Artiva Biotherapeutics ARTV
- First filing
- 24/07/22
- Trades
- 20 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$438K
- Last trade
- 05/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/19 | 05/19 | 27,116 sh | $9.01 | $244,315.16 | −1.7% | |
| Open-market sale10b5-1 plan | 25/12/15 | 25/12/15 | 3,187 sh | $6.00 | $19,122 | −0.3% | |
| Open-market sale10b5-1 plan | 25/11/17 | 25/11/17 | 6,375 sh | $3.38 | $21,547.5 | −1.8% | |
| Open-market sale10b5-1 plan | 25/10/17 | 25/10/17 | 25,500 sh | $6.00 | $153,000 | −6.7% | |
| Open-market sale10b5-1 plan | 25/08/15 | 25/08/18 | 25,500 sh | $2.73 | $69,615 | −6.2% |